UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 743

Sortiert nach

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial

Journal of virology, 2021-04, Vol.95 (9)

2021

Volltextzugriff (PDF)

Self-reported patient history to assess hepatitis B virus serological status during a large screening campaign

Epidemiology and infection, 2019-01, Vol.147, p.1-e16, Article e16

2019

Volltextzugriff (PDF)

Efficacy of protease inhibitor monotherapy vs. triple therapy: meta‐analysis of data from 2303 patients in 13 randomized trials

HIV medicine, 2016-05, Vol.17 (5), p.358-367

2016

Volltextzugriff (PDF)

Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients

Journal of viral hepatitis, 2016-12, Vol.23 (12), p.1017-1026

2016

Volltextzugriff (PDF)

Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum

European journal of clinical microbiology & infectious diseases, 2013, Vol.32 (1), p.107-113

2013

Volltextzugriff (PDF)

Clinical and microbiological determinants of severe and fatal outcomes in patients infected with Enterobacteriaceae producing extended-spectrum β-lactamase

European journal of clinical microbiology & infectious diseases, 2017-07, Vol.36 (7), p.1261-1268

2017

Volltextzugriff (PDF)

HIV/hepatitis B virus co-infection: current challenges and new strategies

Journal of antimicrobial chemotherapy, 2010-01, Vol.65 (1), p.10-17

2010

Volltextzugriff (PDF)

Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial

HIV medicine, 2017-01, Vol.18 (1), p.5-12

2017

Volltextzugriff (PDF)

DNA Ligase IV Mutations Identified in Patients Exhibiting Developmental Delay and Immunodeficiency

Molecular cell, 2001-12, Vol.8 (6), p.1175-1185

2001

Volltextzugriff (PDF)

Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus

Journal of viral hepatitis, 2010-01, Vol.17 (1), p.65-76

2010

Volltextzugriff (PDF)

Investigation of the phototoxicity and cytotoxicity of naproxen, a non-steroidal anti-inflammatory drug, in human fibroblasts

Photochemical & photobiological sciences, 2013-05, Vol.12 (5), p.911-922

2013

Volltextzugriff (PDF)

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.614-619

2010

Volltextzugriff (PDF)

Effects of HIV Protease Inhibitors on Cardiac Conduction Velocity in Unselected HIV-Infected Patients

Clinical pharmacology and therapeutics, 2011-09, Vol.90 (3), p.442-448

2011

Volltextzugriff (PDF)

Pooled week 96 results of the phase III DUET‐1 and DUET‐2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest

HIV medicine, 2012-08, Vol.13 (7), p.427-435

2012

Volltextzugriff (PDF)

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.2910-2919

2010

Volltextzugriff (PDF)

Quantification of Human Immunodeficiency Virus Type 1 Proviral Load by a TaqMan Real-Time PCR Assay

Journal of Clinical Microbiology, 2001-04, Vol.39 (4), p.1303-1310, Article 1303

2001

Volltextzugriff (PDF)

Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal

Journal of medical virology, 2017-03, Vol.89 (3), p.484-488

2017

Volltextzugriff (PDF)

Long‐term (96‐week) follow‐up of antiretroviral‐naïve HIV‐infected patients treated with first‐line lopinavir/ritonavir monotherapy in the MONARK trial

HIV medicine, 2010-02, Vol.11 (2), p.137-142

2010

Volltextzugriff (PDF)

Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE]

HIV medicine, 2013-08, Vol.14 (7), p.410-420

2013

Volltextzugriff (PDF)

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

The Lancet (British edition), 2006-07, Vol.368 (9532), p.287-298

2006

Volltextzugriff (PDF)

Anti-Toxoplasma Activities of 24 Quinolones and Fluoroquinolones In Vitro: Prediction of Activity by Molecular Topology and Virtual Computational Techniques

Antimicrobial Agents and Chemotherapy, 2000-10, Vol.44 (10), p.2771-2776

2000

Volltextzugriff (PDF)

Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa

Journal of antimicrobial chemotherapy, 2018-11, Vol.73 (11), p.3143-3147

2018

Volltextzugriff (PDF)

Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS

AIDS (London), 1997-11, Vol.11 (14), p.1725-1730

1997

Volltextzugriff (PDF)

The Ogg1 protein of Saccharomyces cerevisiae: a 7,8-dihydro-8-oxoguanine DNA glycosylase/AP lyase whose lysine 241 is a critical residue for catalytic activity

Nucleic acids research, 1997-08, Vol.25 (16), p.3204

1997

Volltextzugriff (PDF)

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013

Euro surveillance : bulletin européen sur les maladies transmissibles, 2014-04, Vol.19 (14), p.1

2014

Volltextzugriff (PDF)

1 – 25 von 743

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(643)
Mit Volltextzugriff
(622)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(459)
Life Sciences & Biomedicine
(427)
Humans
(420)
Male
(280)
Infectious Diseases
(269)
Female
(257)
Adult
(251)
Biological And Medical Sciences
(240)
Medical Sciences
(214)
Middle Aged
(199)
Hiv Infections - Drug Therapy
(167)
Aids/hiv
(153)
Human Immunodeficiency Virus
(150)
Immunology
(147)
Virology
(143)
Hiv
(132)
Viral Diseases
(126)
Human Viral Diseases
(125)
Life Sciences
(119)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(117)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial

Self-reported patient history to assess hepatitis B virus serological status during a large screening campaign

Efficacy of protease inhibitor monotherapy vs. triple therapy: meta‐analysis of data from 2303 patients in 13 randomized trials

Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients

Evolving microbiological epidemiology and high fetal mortality in 135 cases of bacteremia during pregnancy and postpartum

Clinical and microbiological determinants of severe and fatal outcomes in patients infected with Enterobacteriaceae producing extended-spectrum β-lactamase

HIV/hepatitis B virus co-infection: current challenges and new strategies

Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial

DNA Ligase IV Mutations Identified in Patients Exhibiting Developmental Delay and Immunodeficiency

Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus

Investigation of the phototoxicity and cytotoxicity of naproxen, a non-steroidal anti-inflammatory drug, in human fibroblasts

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Effects of HIV Protease Inhibitors on Cardiac Conduction Velocity in Unselected HIV-Infected Patients

Pooled week 96 results of the phase III DUET‐1 and DUET‐2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest

Gag Mutations Can Impact Virological Response to Dual-Boosted Protease Inhibitor Combinations in Antiretroviral-Naïve HIV-Infected Patients

Quantification of Human Immunodeficiency Virus Type 1 Proviral Load by a TaqMan Real-Time PCR Assay

Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal

Long‐term (96‐week) follow‐up of antiretroviral‐naïve HIV‐infected patients treated with first‐line lopinavir/ritonavir monotherapy in the MONARK trial

Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE]

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

Anti-Toxoplasma Activities of 24 Quinolones and Fluoroquinolones In Vitro: Prediction of Activity by Molecular Topology and Virtual Computational Techniques

Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa

Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS

The Ogg1 protein of Saccharomyces cerevisiae: a 7,8-dihydro-8-oxoguanine DNA glycosylase/AP lyase whose lysine 241 is a critical residue for catalytic activity

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013

Suchergebnisse filtern